JG
AXSM icon

Jain Global’s Axsome Therapeutics AXSM Stock Holding History

Jain Global’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.75M Buy
27,569
+24,278
+738% +$5.27M 0.03% 490
2026
Q1 		$556K Buy
+3,291
New +$568K ﹤0.01% 914
2025
Q4 		– Sell
-9,007
Closed -$1.09M – 1228
2025
Q3 		$1.09M Buy
+9,007
New +$1.01M 0.01% 631

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Jain Global's AXSM Position: Q2 2026 in Review

Jain Global increased its Axsome Therapeutics (AXSM) stake by 738% in Q2 2026, buying an estimated $5.27M and bringing the position to 27,569 shares worth $6.75M. The position accounts for 0.03% of the portfolio, ranked #490.

Jain Global first reported a position in AXSM in Q3 2025 and has held it in 3 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Jain Global held 27,569 shares of Axsome Therapeutics worth $6.75M as of Q2 2026.
  • Jain Global bought 24,278 Axsome Therapeutics shares in Q2 2026, an estimated $5.27M.
  • Axsome Therapeutics made up 0.03% of Jain Global's portfolio in Q2 2026, its #490 holding.
  • Jain Global first reported a position in Axsome Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.